Differential diagnosis of renal osteodystrophy

Handbook of Dialysis Therapy

Volumn , Issue , 2008, Pages 965-986

  Nouri, Pouneh ^a   Nikakhtar, Bijan ^a   Llach, Francisco ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80955152764     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4197-9.50078-8     Document Type: Chapter

References (17)

1. Andress DL Vitamin D treatment in chronic kidney disease. Semin Dial 2005, 18:315-321.
2. Differential Diagnosis of Renal Osteodystrophy 1998, Lippincott-Raven, Philadelphia. D.A. Bushinsky (Ed.).
3. Coyne D, et al. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 2006, 47:263-276.
4. Dobrez DG, et al. Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Nephrol Dial Transplant 2004, 19:1174-1181.
5. Friedman PA PTH revisited. Kidney Int 2004, 91:S13-S19.
6. Renal bone disease 1999, 73. Kidney International. R. Gokal, A. Hutchison, E. Ritz, E. Slatopolsky (Eds.).
7. Llach F, Jordi B Renal osteodystrophies. The Kidney 2000, 2103. Saunders WB, Philadelphia. B.M. Brenner, F.C. Rector (Eds.).
8. Moe SM, et al. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 2005, 20:2186-2193.
9. Persy VP, et al. Lanthanum: A safe phosphate binder. Semin Dial 2006, 19(3):195-199.
10. Ritz E The clinical management of hyperphosphatemia. J Nephrol 2005, 18:221-228.
11. Sprague SM, et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003, 63:1483-1490.
12. Teng M, et al. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 2005, 16:1115-1125.
13. Yudd M, Llach F Renal osteodystrophy. Dialysis and Transplantation: A Companion to Brenner and Rector's The Kidney 2000, 253. Saunders WB, Philadelphia. W.F. Owen, B.J.P. Pereira, M.H. Sayegh (Eds.).
14. Comprehensive coverage of the pathogenesis of renal osteodystrophy and its clinical aspects.
15. This supplement highlights the findings of the current research in this field.
16. An encyclopedic approach to renal bone disease: causes, pathogenesis, clinical status, and therapy.
17. This chapter focuses on the clinical manifestations and treatment of renal osteodystrophy.